Benjamin A. Pinsky

The paper evaluates using residual plasma from heparin separators for cfDNA testing, showing high concordance with EDTA and Streck samples for methylation, fragmentation, and viral detection.

RMC-113 inhibits PIP4K2C and PIKfyve, reversing SARS-CoV-2-induced autophagic flux impairment and showing antiviral effects.

The paper evaluates the effectiveness of an XBB.1.5 monovalent booster vaccine, showing improved antibody binding and neutralization against SARS-CoV-2 Omicron variants.

The paper integrates multi-omic data to identify genetic and microbiome factors associated with severe COVID-19, independent of ancestry and social factors.

The paper uses CRISPR screens to identify mucins as key host factors that restrict SARS-CoV-2 infection in human lung cells.

The paper uses long-read sequencing to identify novel SARS-CoV-2 transcripts and variants, revealing a complex transcriptome landscape.

This study examines B cell clonal expansion and convergent antibody responses in SARS-CoV-2 patients, identifying shared features with SARS-CoV.

This paper develops a high-throughput method to generate host and pathogen genomic data from single nasopharyngeal swabs of COVID-19 patients.

This study compares metagenomic DNA sequencing with pathogen-directed PCR for diagnosing intraocular infections, finding DNA-seq detects more pathogens and identifies drug resistance mutations.